Aberrant promoter hypermethylation of mir-335 and mir-145 is involved in breast cancer pd-l1 overexpression

HIGHLIGHTS

• who: Sara Hajibabaei from the DepartmentAzad University have published the research: Aberrant promoter hypermethylation of miR-335 and miR-145 is involved in breast cancer PD-L1 overexpression, in the Journal: Scientific Reports Scientific Reports of May/14,/2022
• what: To further illustrate PD-L1 as a direct target of miR-335 and -145, the authors examine the significance of PD-L1 in miR-335 and -145-mediated cell survival. The authors investigate miR-335 and -145 promoter hypermethylation in breast cancer. The authors investigated the expression level of PD-L1 and its relationship with . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.